{"id":32079,"date":"2026-09-21T14:40:00","date_gmt":"2026-09-21T21:40:00","guid":{"rendered":"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss-copy"},"modified":"2026-09-22T04:49:12","modified_gmt":"2026-09-22T11:49:12","slug":"what-is-the-tirzepatide-starting-dose-for-weight-loss","status":"publish","type":"post","link":"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss","title":{"rendered":"What is the tirzepatide starting dose for weight loss?"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">The tirzepatide starting dose for weight loss is <\/span><b>2.5 mg, injected once weekly, for the first four weeks<\/b><span style=\"font-weight: 400;\"> \u2014 whether you&#8217;re prescribed <\/span><a href=\"https:\/\/getheally.com\/patients\/zepbound\"><span style=\"font-weight: 400;\">Zepbound<\/span><\/a><span style=\"font-weight: 400;\"> or Mounjaro. That&#8217;s the FDA-confirmed protocol as of the current 2026 prescribing information, and it hasn&#8217;t changed since tirzepatide&#8217;s original approval.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">That starting number surprises some patients, since it&#8217;s well below the doses that produced the big weight-loss numbers in clinical trials. Here&#8217;s why it&#8217;s set that low, and what happens after those first four weeks.<\/span><\/p>\n<h2 id=\"key-takeaways\"><span style=\"font-weight: 400;\">Key takeaways<\/span><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>The starting dose is 2.5 mg once weekly, for the first 4 weeks<\/b><span style=\"font-weight: 400;\">, on both Zepbound and Mounjaro \u2014 confirmed unchanged in the current 2026 FDA label.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>2.5 mg is an introductory dose only.<\/b><span style=\"font-weight: 400;\"> It&#8217;s not approved as a maintenance dose, and it&#8217;s not the dose that drives significant weight loss in trials.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>The dose increases by 2.5 mg every 4 weeks<\/b><span style=\"font-weight: 400;\"> after that, moving toward a maintenance dose of 5 mg, 10 mg, or 15 mg based on response and tolerability.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>The low starting dose exists to reduce gastrointestinal side effects<\/b><span style=\"font-weight: 400;\"> \u2014 nausea, vomiting, and diarrhea are most common early in treatment and during dose increases.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">You inject the same 2.5 mg dose every week for the full 4 weeks \u2014 there&#8217;s no dose increase within that initial period, even if side effects are minimal.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">If you&#8217;re switching from another GLP-1 drug, your starting dose may differ from the standard schedule \u2014 this should be decided with your provider, not assumed.<\/span><\/li>\n<\/ul>\n<h2 id=\"why-2-5-mg-and-not-a-higher-starting-dose\"><span style=\"font-weight: 400;\">Why 2.5 mg, and not a higher starting dose?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Tirzepatide activates two receptors \u2014 GLP-1 and GIP \u2014 and the body needs time to adjust to that activation. Starting at a low dose and increasing gradually is a deliberate strategy to reduce the gastrointestinal side effects that are most likely early in treatment: nausea, vomiting, diarrhea, and constipation.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">This isn&#8217;t unique to tirzepatide \u2014 every approved GLP-1 and dual-agonist weight-loss drug uses a similar slow-titration approach. Jumping straight to a higher dose would likely produce more severe side effects without meaningfully speeding up results, since the first weeks on any dose are more about tolerability than measurable weight loss.<\/span><\/p>\n<h2 id=\"the-starting-titration-schedule\"><span style=\"font-weight: 400;\">The starting titration schedule<\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th><b>Weeks on treatment<\/b><\/th>\n<th><b>Dose<\/b><\/th>\n<th><b>Purpose<\/b><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><span style=\"font-weight: 400;\">Weeks 1\u20134<\/span><\/td>\n<td><span style=\"font-weight: 400;\">2.5 mg<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Introductory dose \u2014 tolerability, not treatment effect<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Weeks 5\u20138<\/span><\/td>\n<td><span style=\"font-weight: 400;\">5 mg<\/span><\/td>\n<td><span style=\"font-weight: 400;\">First increase; still below most maintenance doses<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Weeks 9\u201312<\/span><\/td>\n<td><span style=\"font-weight: 400;\">7.5 mg<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Second increase<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Weeks 13\u201316<\/span><\/td>\n<td><span style=\"font-weight: 400;\">10 mg<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Often a maintenance-range dose<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Weeks 17\u201320<\/span><\/td>\n<td><span style=\"font-weight: 400;\">12.5 mg<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Additional increase if needed<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Week 21+<\/span><\/td>\n<td><span style=\"font-weight: 400;\">15 mg<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Maximum dose, if tolerated and needed<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span style=\"font-weight: 400;\">Each step requires at least 4 weeks on the current dose before increasing \u2014 this isn&#8217;t optional or something to shorten on your own. Your provider may also pause an increase, or step back down a level, if side effects are significant at any point.<\/span><\/p>\n<h2 id=\"what-to-expect-during-the-first-4-weeks\"><span style=\"font-weight: 400;\">What to expect during the first 4 weeks<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Most patients notice mild GI symptoms in the first days on 2.5 mg \u2014 some nausea, a change in appetite, occasional stomach discomfort. These are usually described as mild to moderate and tend to ease as the body adjusts, though individual experiences vary.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Significant weight loss typically isn&#8217;t the goal of the 2.5 mg phase. It&#8217;s a tolerability step. Most of the measurable weight-loss effect documented in trials comes from the maintenance doses (5\u201315 mg), not the starting dose \u2014 so it&#8217;s normal not to see dramatic changes in the first month.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Injection technique matters from the start: rotate injection sites (abdomen, thigh, or upper arm), inject subcutaneously, and take it on the same day each week regardless of meals.<\/span><\/p>\n<h2 id=\"if-youre-switching-from-another-glp-1-drug\"><span style=\"font-weight: 400;\">If you&#8217;re switching from another GLP-1 drug<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Patients moving from semaglutide (Ozempic, Wegovy) to tirzepatide don&#8217;t automatically start at 2.5 mg in every case \u2014 this depends on your current dose, how long you&#8217;ve been on it, and your provider&#8217;s clinical judgment. Some providers start at the standard 2.5 mg regardless of prior GLP-1 use; others adjust the starting point. This is a decision to make directly with your prescriber, not something to determine from a dosing chart alone.<\/span><\/p>\n<h2 id=\"missed-a-dose-during-the-starting-phase\"><span style=\"font-weight: 400;\">Missed a dose during the starting phase?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">If you miss your weekly 2.5 mg dose and it&#8217;s been less than 4 days, take it as soon as you remember, then resume your normal weekly schedule. If more than 4 days have passed, skip the missed dose and take your next one on the regular schedule. Don&#8217;t double up to make up for a missed dose \u2014 this applies during the starting phase just as much as at maintenance doses.<\/span><\/p>\n<h2 id=\"what-comes-after-the-starting-dose\"><span style=\"font-weight: 400;\">What comes after the starting dose<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Once you&#8217;re past the initial 2.5 mg phase, your provider will guide you through the escalation steps toward a maintenance dose \u2014 typically 5 mg, 10 mg, or 15 mg, depending on your response and tolerability. Our guide on <\/span><a href=\"https:\/\/getheally.com\/patients\/news\/what-is-the-maintenance-dose-of-tirzepatide\"><span style=\"font-weight: 400;\">tirzepatide&#8217;s maintenance dose<\/span><\/a><span style=\"font-weight: 400;\"> covers what to expect once you get there, including how long most patients stay on their maintenance dose and the signs it may need adjusting.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">If GI side effects become significant at any point during titration, our guide on <\/span><a href=\"https:\/\/getheally.com\/patients\/news\/how-to-know-when-your-glp-1-dose-is-too-high\"><span style=\"font-weight: 400;\">recognizing when a GLP-1 dose is too high<\/span><\/a><span style=\"font-weight: 400;\"> covers the warning signs worth flagging to your provider.<\/span><\/p>\n<h2 id=\"conclusion\"><span style=\"font-weight: 400;\">Conclusion<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">The tirzepatide starting dose for weight loss is 2.5 mg once weekly for the first four weeks, on both Zepbound and Mounjaro \u2014 a deliberately low, unchanged-since-approval dose meant to build tolerability before the dose increases toward a maintenance level. It&#8217;s not the dose that drives significant weight loss, so it&#8217;s normal to see modest results in the first month. What matters during this phase is sticking to the weekly schedule and giving your body the full four weeks before any increase.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">If you&#8217;re ready to start tirzepatide or want a provider to walk through your specific titration plan, <\/span><a href=\"https:\/\/getheally.com\/f\/vshop-book_appt?visit_type_first=true&amp;visit_type_ids=3070\"><span style=\"font-weight: 400;\">book a free consultation with Heally<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<h2 id=\"faq\"><span style=\"font-weight: 400;\">FAQ<\/span><\/h2>\n<p><b>What is the starting dose of tirzepatide for weight loss?<\/b><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">2.5 mg, injected once weekly, for the first four weeks. This applies to both Zepbound and Mounjaro and hasn&#8217;t changed in the current 2026 FDA prescribing information.<\/span><\/p>\n<p><b>Can I start at a higher dose than 2.5 mg?<\/b><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">No, not under standard FDA-approved dosing. The 2.5 mg starting dose is required for treatment initiation regardless of your target maintenance dose, to reduce the risk of severe gastrointestinal side effects.<\/span><\/p>\n<p><b>How long do you stay on the 2.5 mg starting dose?<\/b><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Four weeks minimum. Your provider may extend this if you&#8217;re experiencing significant side effects, but it can&#8217;t be shortened.<\/span><\/p>\n<p><b>Will I lose weight on the 2.5 mg starting dose?<\/b><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Some patients notice early changes, but the 2.5 mg dose isn&#8217;t approved as a maintenance dose and isn&#8217;t where most of the measurable weight loss documented in clinical trials occurs. Meaningful results typically build as you reach maintenance-range doses.<\/span><\/p>\n<p><b>What happens after the first 4 weeks on 2.5 mg?<\/b><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Your dose increases to 5 mg for the next 4 weeks, then continues increasing in 2.5 mg steps roughly every 4 weeks until you reach a maintenance dose your provider determines is appropriate.<\/span><\/p>\n<p><b>Do I start at 2.5 mg if I&#8217;m switching from semaglutide?<\/b><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Not automatically in every case. This depends on your current dose and how long you&#8217;ve been on it. Talk to your provider directly rather than assuming the standard schedule applies.<\/span><\/p>\n<p><b>What if I miss my dose during the starting phase?<\/b><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">If it&#8217;s been less than 4 days since your missed dose, take it as soon as you remember. If more than 4 days have passed, skip it and resume your regular weekly schedule at the next dose. Never double up.<\/span><\/p>\n<p><b>Is the starting dose the same for Zepbound and Mounjaro?<\/b><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Yes. Both are tirzepatide at the same doses, and both use the identical 2.5 mg starting dose and titration schedule under current FDA labeling.<\/span><\/p>\n<p><b>Related reading on Heally:<\/b><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/getheally.com\/patients\/news\/what-is-the-maintenance-dose-of-tirzepatide\"><span style=\"font-weight: 400;\">What is the maintenance dose of tirzepatide?<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/getheally.com\/patients\/news\/what-is-tirzepatide-microdosing-and-can-lower-doses-be-effective\"><span style=\"font-weight: 400;\">What is tirzepatide microdosing?<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/getheally.com\/patients\/news\/how-to-get-tirzepatide-with-insurance\"><span style=\"font-weight: 400;\">How to get tirzepatide with insurance<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/getheally.com\/patients\/news\/mounjaro-vs-zepbound-understanding-the-difference\"><span style=\"font-weight: 400;\">Mounjaro vs Zepbound: what&#8217;s actually different<\/span><\/a><\/li>\n<\/ul>\n<h2 id=\"sources\"><span style=\"font-weight: 400;\">Sources<\/span><\/h2>\n<ol>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">FDA \u2014 <\/span><a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2026\/217806s042lbl.pdf\"><span style=\"font-weight: 400;\">Zepbound prescribing information (2026)<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">FDA \u2014 <\/span><a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2026\/215866s041lbl.pdf\"><span style=\"font-weight: 400;\">Mounjaro prescribing information (2026)<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">PubMed \u2014 <\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35658024\/\"><span style=\"font-weight: 400;\">SURMOUNT-1 trial results<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Eli Lilly \u2014 <\/span><a href=\"https:\/\/zepbound.lilly.com\/how-to-use\"><span style=\"font-weight: 400;\">Zepbound usage guide<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">FDA \u2014 <\/span><a href=\"https:\/\/www.fda.gov\/medwatch\"><span style=\"font-weight: 400;\">MedWatch adverse event reporting<\/span><\/a><\/li>\n<\/ol>\n<p><i><span style=\"font-weight: 400;\">Medical disclaimer: This article is for informational purposes and reflects current FDA prescribing information as of September 2026. It does not replace medical advice. Always follow your provider&#8217;s specific dosing instructions, and consult a licensed healthcare provider before starting, stopping, or changing any prescription medication.<\/span><\/i><\/p>\n","protected":false},"excerpt":{"rendered":"The tirzepatide starting dose for weight loss is 2.5 mg, injected once weekly, for the first four weeks&hellip;\n","protected":false},"author":10,"featured_media":29849,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1829,1794],"tags":[1831,2399,1830,1963,1832],"class_list":{"0":"post-32079","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-tirzepatide","8":"category-weight-loss","9":"tag-mounjaro","10":"tag-starting-dose","11":"tag-tirzepatide","12":"tag-weight-management","13":"tag-zepbound"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>What is the tirzepatide starting dose for weight loss? - Heally<\/title>\n<meta name=\"description\" content=\"Learn about the recommended tirzepatide starting dose for weight loss, how it aids in managing obesity, and key considerations for starting treatment\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"What is the tirzepatide starting dose for weight loss? - Heally\" \/>\n<meta property=\"og:description\" content=\"Learn about the recommended tirzepatide starting dose for weight loss, how it aids in managing obesity, and key considerations for starting treatment\" \/>\n<meta property=\"og:url\" content=\"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss\" \/>\n<meta property=\"og:site_name\" content=\"Heally\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/getheally.com\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-21T21:40:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-22T11:49:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2024\/12\/tirzepatide_starting_dose.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"563\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ben Krasne MD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ben Krasne MD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss#article\",\"isPartOf\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss\"},\"author\":{\"name\":\"Ben Krasne MD\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#\/schema\/person\/133ab039fcce2b4f2ef87ae214ab9211\"},\"headline\":\"What is the tirzepatide starting dose for weight loss?\",\"datePublished\":\"2026-09-21T21:40:00+00:00\",\"dateModified\":\"2026-09-22T11:49:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss\"},\"wordCount\":1348,\"publisher\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss#primaryimage\"},\"thumbnailUrl\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2024\/12\/tirzepatide_starting_dose.jpg\",\"keywords\":[\"mounjaro\",\"Starting Dose\",\"tirzepatide\",\"weight management\",\"zepbound\"],\"articleSection\":[\"Tirzepatide\",\"Weight Loss\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss\",\"url\":\"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss\",\"name\":\"What is the tirzepatide starting dose for weight loss? - Heally\",\"isPartOf\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss#primaryimage\"},\"image\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss#primaryimage\"},\"thumbnailUrl\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2024\/12\/tirzepatide_starting_dose.jpg\",\"datePublished\":\"2026-09-21T21:40:00+00:00\",\"dateModified\":\"2026-09-22T11:49:12+00:00\",\"description\":\"Learn about the recommended tirzepatide starting dose for weight loss, how it aids in managing obesity, and key considerations for starting treatment\",\"breadcrumb\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss#primaryimage\",\"url\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2024\/12\/tirzepatide_starting_dose.jpg\",\"contentUrl\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2024\/12\/tirzepatide_starting_dose.jpg\",\"width\":1000,\"height\":563,\"caption\":\"tirzepatide starting dose recommended by doctor\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/getheally.com\/patients\/news\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"What is the tirzepatide starting dose for weight loss?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#website\",\"url\":\"https:\/\/getheally.com\/patients\/news\/\",\"name\":\"Heally\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/getheally.com\/patients\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#organization\",\"name\":\"Heally\",\"url\":\"https:\/\/getheally.com\/patients\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2019\/05\/heallybl.png\",\"contentUrl\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2019\/05\/heallybl.png\",\"width\":152,\"height\":52,\"caption\":\"Heally\"},\"image\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/getheally.com\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#\/schema\/person\/133ab039fcce2b4f2ef87ae214ab9211\",\"name\":\"Ben Krasne MD\",\"pronouns\":\"Meet Dr. Benjamin Krasne, M.D., an anesthesiology and preventive medicine physician specializing in longevity and metabolic health at Heally\",\"description\":\"Dr. Benjamin Krasne is a board-certified Anesthesiologist with deep expertise in preventive medicine, metabolic health, and longevity optimization. He earned his medical degree from the University of Miami Leonard M. Miller School of Medicine in 2013 and completed his Anesthesiology residency at the University of Miami \/ Jackson Health System \u2014 one of the largest and most complex medical centers in the United States, providing broad exposure to high-acuity patient care and pharmacology. Beyond his anesthesiology training, Dr. Krasne has built specialized expertise in the root causes of metabolic and age-related disease. His approach draws on cardiovascular, hormonal, and metabolic science to proactively optimize health markers rather than waiting for disease to manifest. He holds active medical licenses across 13 U.S. states, reflecting his commitment to expanding access to evidence-based preventive care through telehealth. At Heally, Dr. Krasne is the primary medical reviewer for the platform's largest content category \u2014 GLP-1 weight loss medications, including semaglutide (Wegovy, Ozempic, Rybelsus), tirzepatide (Zepbound, Mounjaro), oral Wegovy, longevity protocols, NAD+ therapy, sermorelin, methylene blue, acarbose, and peptide therapies. His pharmacological background and preventive medicine focus make him ideally suited to review clinical content on metabolic optimization.\",\"sameAs\":[\"https:\/\/www.parkwayrestorativedentistry.com\/dr-benjamin-krasne\"],\"url\":\"https:\/\/getheally.com\/patients\/news\/author\/ben-krasne-md\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"What is the tirzepatide starting dose for weight loss? - Heally","description":"Learn about the recommended tirzepatide starting dose for weight loss, how it aids in managing obesity, and key considerations for starting treatment","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss","og_locale":"en_US","og_type":"article","og_title":"What is the tirzepatide starting dose for weight loss? - Heally","og_description":"Learn about the recommended tirzepatide starting dose for weight loss, how it aids in managing obesity, and key considerations for starting treatment","og_url":"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss","og_site_name":"Heally","article_publisher":"https:\/\/getheally.com","article_published_time":"2026-09-21T21:40:00+00:00","article_modified_time":"2026-09-22T11:49:12+00:00","og_image":[{"width":1000,"height":563,"url":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2024\/12\/tirzepatide_starting_dose.jpg","type":"image\/jpeg"}],"author":"Ben Krasne MD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ben Krasne MD","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss#article","isPartOf":{"@id":"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss"},"author":{"name":"Ben Krasne MD","@id":"https:\/\/getheally.com\/patients\/news\/#\/schema\/person\/133ab039fcce2b4f2ef87ae214ab9211"},"headline":"What is the tirzepatide starting dose for weight loss?","datePublished":"2026-09-21T21:40:00+00:00","dateModified":"2026-09-22T11:49:12+00:00","mainEntityOfPage":{"@id":"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss"},"wordCount":1348,"publisher":{"@id":"https:\/\/getheally.com\/patients\/news\/#organization"},"image":{"@id":"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss#primaryimage"},"thumbnailUrl":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2024\/12\/tirzepatide_starting_dose.jpg","keywords":["mounjaro","Starting Dose","tirzepatide","weight management","zepbound"],"articleSection":["Tirzepatide","Weight Loss"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss","url":"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss","name":"What is the tirzepatide starting dose for weight loss? - Heally","isPartOf":{"@id":"https:\/\/getheally.com\/patients\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss#primaryimage"},"image":{"@id":"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss#primaryimage"},"thumbnailUrl":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2024\/12\/tirzepatide_starting_dose.jpg","datePublished":"2026-09-21T21:40:00+00:00","dateModified":"2026-09-22T11:49:12+00:00","description":"Learn about the recommended tirzepatide starting dose for weight loss, how it aids in managing obesity, and key considerations for starting treatment","breadcrumb":{"@id":"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss#primaryimage","url":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2024\/12\/tirzepatide_starting_dose.jpg","contentUrl":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2024\/12\/tirzepatide_starting_dose.jpg","width":1000,"height":563,"caption":"tirzepatide starting dose recommended by doctor"},{"@type":"BreadcrumbList","@id":"https:\/\/getheally.com\/patients\/news\/what-is-the-tirzepatide-starting-dose-for-weight-loss#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/getheally.com\/patients\/news"},{"@type":"ListItem","position":2,"name":"What is the tirzepatide starting dose for weight loss?"}]},{"@type":"WebSite","@id":"https:\/\/getheally.com\/patients\/news\/#website","url":"https:\/\/getheally.com\/patients\/news\/","name":"Heally","description":"","publisher":{"@id":"https:\/\/getheally.com\/patients\/news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/getheally.com\/patients\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/getheally.com\/patients\/news\/#organization","name":"Heally","url":"https:\/\/getheally.com\/patients\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/getheally.com\/patients\/news\/#\/schema\/logo\/image\/","url":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2019\/05\/heallybl.png","contentUrl":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2019\/05\/heallybl.png","width":152,"height":52,"caption":"Heally"},"image":{"@id":"https:\/\/getheally.com\/patients\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/getheally.com"]},{"@type":"Person","@id":"https:\/\/getheally.com\/patients\/news\/#\/schema\/person\/133ab039fcce2b4f2ef87ae214ab9211","name":"Ben Krasne MD","pronouns":"Meet Dr. Benjamin Krasne, M.D., an anesthesiology and preventive medicine physician specializing in longevity and metabolic health at Heally","description":"Dr. Benjamin Krasne is a board-certified Anesthesiologist with deep expertise in preventive medicine, metabolic health, and longevity optimization. He earned his medical degree from the University of Miami Leonard M. Miller School of Medicine in 2013 and completed his Anesthesiology residency at the University of Miami \/ Jackson Health System \u2014 one of the largest and most complex medical centers in the United States, providing broad exposure to high-acuity patient care and pharmacology. Beyond his anesthesiology training, Dr. Krasne has built specialized expertise in the root causes of metabolic and age-related disease. His approach draws on cardiovascular, hormonal, and metabolic science to proactively optimize health markers rather than waiting for disease to manifest. He holds active medical licenses across 13 U.S. states, reflecting his commitment to expanding access to evidence-based preventive care through telehealth. At Heally, Dr. Krasne is the primary medical reviewer for the platform's largest content category \u2014 GLP-1 weight loss medications, including semaglutide (Wegovy, Ozempic, Rybelsus), tirzepatide (Zepbound, Mounjaro), oral Wegovy, longevity protocols, NAD+ therapy, sermorelin, methylene blue, acarbose, and peptide therapies. His pharmacological background and preventive medicine focus make him ideally suited to review clinical content on metabolic optimization.","sameAs":["https:\/\/www.parkwayrestorativedentistry.com\/dr-benjamin-krasne"],"url":"https:\/\/getheally.com\/patients\/news\/author\/ben-krasne-md"}]}},"_links":{"self":[{"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/posts\/32079","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/comments?post=32079"}],"version-history":[{"count":33,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/posts\/32079\/revisions"}],"predecessor-version":[{"id":37888,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/posts\/32079\/revisions\/37888"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/media\/29849"}],"wp:attachment":[{"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/media?parent=32079"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/categories?post=32079"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/tags?post=32079"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}